Cargando…
Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307419/ https://www.ncbi.nlm.nih.gov/pubmed/37387820 http://dx.doi.org/10.1155/2023/9830309 |
Ejemplares similares
-
Retracted: Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Changes in the Quality of Life, Psychological Status, Medication Compliance, and Prognosis of Patients with Acute Myocardial Infarction after PCI by Applying PDCA Cycle Management Model
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Investigation on Family Support System and Willingness of Patients to Participate in Cardiac Rehabilitation after Percutaneous Coronary Intervention
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)